ALNY Competition Analysis

Alnylam Pharmaceuticals, Inc. Peer Comparison

Metric	Value	Ranking
Market Cap	$35.1 Billion	2/18	SGEN $43.2B	ALNY $35.1B	UTHR $15.2B	BMRN $13.5B	KRTX $12.6B	INCY $12.6B	HALO $7.9B	EXEL $7.7B	RETA $6.6B	BPMC $5.7B	ISEE $5.5B	RARE $5.3B	KRYS $5.3B	MDGL $5.1B	APLS $4.3B	DAWN $1.2B	WVE $682.3M	PRQR $147.0M
Gross Margin	90%	7/18	EXEL 100%	RETA 96%	MDGL 96%	BPMC 92%	INCY 91%	DAWN 91%	ALNY 90%	UTHR 89%	WVE 89%	KRYS 89%	PRQR 89%	APLS 88%	BMRN 80%	RARE 79%	HALO 75%	SGEN 75%	ISEE 0%	KRTX 0%
Profit Margin	-3%	9/18	RETA 100%	HALO 40%	UTHR 39%	EXEL 35%	KRYS 22%	BMRN 15%	ISEE 0%	KRTX 0%	ALNY -3%	APLS -19%	SGEN -33%	BPMC -36%	INCY -43%	PRQR -43%	DAWN -54%	RARE -90%	MDGL -100%	WVE -100%
EBITDA margin	10%	6/18	HALO 59%	UTHR 47%	EXEL 43%	KRYS 33%	BMRN 18%	ALNY 10%	APLS -15%	BPMC -29%	SGEN -34%	INCY -44%	PRQR -48%	RARE -73%	ISEE -100%	KRTX -100%	WVE -167%	RETA -356%	MDGL -1110%	DAWN -1396%
Quarterly Revenue	$659.8 Million	4/18	INCY $1.0B	UTHR $714.9M	BMRN $708.7M	ALNY $659.8M	SGEN $648.7M	EXEL $637.2M	HALO $231.4M	APLS $199.7M	RARE $147.0M	BPMC $138.2M	KRYS $70.3M	RETA $22.7M	WVE $19.7M	MDGL $14.6M	DAWN $8.2M	PRQR $7.0M	ISEE $0	KRTX $0
Quarterly Earnings	-$16.9 Million	9/18	UTHR $278.1M	EXEL $226.1M	RETA $193.0M	BMRN $107.2M	HALO $93.2M	KRYS $15.6M	PRQR -$3.0M	DAWN -$4.4M	ALNY -$16.9M	WVE -$32.9M	APLS -$37.7M	BPMC -$50.0M	ISEE -$70.6M	KRTX -$113.8M	RARE -$131.6M	MDGL -$152.0M	SGEN -$215.8M	INCY -$444.6M
Quarterly Free Cash Flow	$116.1 Million	2/18	UTHR $187.1M	ALNY $116.1M	BMRN $96.9M	HALO $53.2M	EXEL -$0	MDGL -$0	KRYS -$5.3M	PRQR -$7.1M	APLS -$8.4M	WVE -$27.2M	BPMC -$50.6M	ISEE -$50.8M	DAWN -$66.3M	RETA -$70.2M	SGEN -$79.8M	RARE -$81.5M	KRTX -$111.9M	INCY -$631.1M
Trailing 4 Quarters Revenue	$2.3 Billion	4/18	BMRN $648.1B	INCY $3.9B	UTHR $2.6B	ALNY $2.3B	SGEN $2.3B	EXEL $2.0B	HALO $873.3M	APLS $598.5M	RARE $481.3M	BPMC $362.8M	KRYS $157.7M	WVE $110.5M	RETA $24.4M	PRQR $16.9M	MDGL $14.6M	DAWN $8.8M	KRTX $654,000	ISEE $0
Trailing 4 Quarters Earnings	-$72.9 Million	8/18	INCY $1.0B	UTHR $714.9M	BMRN $708.7M	ALNY $659.8M	SGEN $648.7M	EXEL $637.2M	HALO $231.4M	APLS $199.7M	RARE $147.0M	BPMC $138.2M	KRYS $70.3M	RETA $22.7M	WVE $19.7M	MDGL $14.6M	DAWN $8.2M	PRQR $7.0M	ISEE -$0	KRTX -$0
Quarterly Earnings Growth	94%	4/18	RETA 362%	EXEL 179%	KRYS 137%	ALNY 94%	DAWN 90%	APLS 69%	PRQR 66%	BPMC 62%	HALO 25%	RARE 18%	UTHR 7%	SGEN -13%	KRTX -49%	WVE -56%	MDGL -77%	BMRN -100%	ISEE -104%	INCY -318%
Annual Earnings Growth	91%	2/18	KRYS 94%	ALNY 91%	EXEL 74%	HALO 74%	RETA 72%	BPMC 61%	APLS 49%	PRQR 33%	WVE 22%	RARE 10%	UTHR 9%	DAWN -15%	SGEN -26%	KRTX -37%	MDGL -60%	ISEE -60%	BMRN -63%	INCY -64%
Quarterly Revenue Growth	107%	5/18	RETA 2885%	PRQR 426%	BPMC 140%	APLS 110%	ALNY 107%	EXEL 36%	RARE 36%	SGEN 27%	UTHR 20%	INCY 9%	HALO 5%	MDGL 0%	KRYS 0%	ISEE 0%	DAWN 0%	WVE -11%	BMRN -100%	KRTX -100%
Annual Revenue Growth	84%	4/18	RETA 596%	PRQR 385%	APLS 161%	ALNY 84%	WVE 81%	BPMC 47%	UTHR 24%	HALO 23%	EXEL 19%	RARE 17%	SGEN 15%	INCY 14%	BMRN 9%	MDGL 0%	KRYS 0%	ISEE 0%	DAWN 0%	KRTX -88%
Cash On Hand	$968.5 Million	4/18	UTHR $1.4B	INCY $987.3M	BMRN $972.2M	ALNY $968.5M	MDGL $494.6M	RARE $486.9M	ISEE $467.6M	SGEN $428.6M	APLS $361.4M	KRYS $345.8M	DAWN $239.6M	EXEL $198.5M	HALO $187.9M	KRTX $185.8M	WVE $154.0M	PRQR $86.8M	BPMC $54.8M	RETA $48.8M
Short Term Debt	$103.6 Million	4/18	BMRN $505.5M	UTHR $400.0M	BPMC $114.7M	ALNY $103.6M	RARE $58.6M	HALO $30.7M	INCY $8.8M	WVE $7.2M	APLS $6.2M	PRQR $5.0M	KRTX $2.8M	RETA $2.5M	KRYS $1.4M	ISEE $774,000	MDGL $557,000	DAWN $190,000	EXEL -$0	SGEN -$0
Long Term Debt	$2.4 Billion	1/18	ALNY $2.4B	HALO $1.5B	RARE $842.2M	BMRN $594.1M	BPMC $550.4M	APLS $457.2M	EXEL $198.0M	RETA $163.5M	SGEN $113.5M	UTHR $100.0M	ISEE $97.0M	INCY $28.7M	WVE $21.7M	KRTX $13.8M	MDGL $0	KRYS $0	PRQR $0	DAWN $0
PE	-1.00	6/18	INCY 129.01	HALO 23.40	EXEL 21.86	UTHR 14.25	BMRN 0.66	ALNY -1.00	RETA -1.00	SGEN -1.00	RARE -1.00	MDGL -1.00	BPMC -1.00	WVE -1.00	APLS -1.00	KRYS -1.00	PRQR -1.00	ISEE -1.00	KRTX -1.00	DAWN -1.00
PS	14.96	8/18	KRTX 19264.95	MDGL 345.85	RETA 269.17	DAWN 138.28	KRYS 33.30	SGEN 18.76	BPMC 15.60	ALNY 14.96	RARE 11.05	HALO 9.04	PRQR 7.91	APLS 7.25	WVE 6.17	UTHR 5.82	EXEL 3.80	INCY 3.25	BMRN 0.02	ISEE -1.00
PB	0.00	18/18	WVE 155.18	RETA 75.22	HALO 27.27	BPMC 17.67	SGEN 16.92	APLS 16.41	RARE 12.30	ISEE 11.55	KRTX 10.05	KRYS 6.26	MDGL 5.91	INCY 4.19	PRQR 4.07	DAWN 3.95	EXEL 3.61	UTHR 2.68	BMRN 2.56	ALNY 0.00
PC	36.21	7/18	RETA 134.44	BPMC 103.31	SGEN 100.70	KRTX 67.80	HALO 42.02	EXEL 38.55	ALNY 36.21	KRYS 15.18	BMRN 13.93	INCY 12.71	APLS 12.00	ISEE 11.79	UTHR 11.24	RARE 10.92	MDGL 10.24	DAWN 5.05	WVE 4.43	PRQR 1.69
Liabilities to Equity	0.00	18/18	WVE 46.49	HALO 5.80	RETA 4.76	BPMC 2.76	RARE 2.74	PRQR 2.59	APLS 2.42	INCY 0.56	SGEN 0.42	BMRN 0.34	EXEL 0.31	DAWN 0.31	ISEE 0.29	MDGL 0.28	UTHR 0.18	KRYS 0.09	KRTX 0.07	ALNY 0.00
ROA	-0.02	7/18	BMRN 292%	HALO 17%	UTHR 16%	EXEL 13%	INCY 2%	KRYS -1%	ALNY -2%	RETA -16%	BPMC -17%	PRQR -20%	SGEN -21%	KRTX -32%	WVE -35%	ISEE -35%	RARE -36%	APLS -37%	DAWN -44%	MDGL -46%
ROE	23.78	1/18	ALNY 2378%	BMRN 390%	HALO 117%	UTHR 19%	EXEL 17%	INCY 3%	KRYS -1%	SGEN -29%	KRTX -34%	ISEE -45%	DAWN -57%	MDGL -60%	BPMC -64%	PRQR -72%	RETA -94%	APLS -126%	RARE -135%	WVE -1671%
Current Ratio	1.00	18/18	KRTX 16.30	KRYS 11.65	UTHR 6.55	MDGL 4.53	ISEE 4.50	DAWN 4.27	EXEL 4.24	BMRN 3.97	SGEN 3.35	INCY 2.80	APLS 1.41	PRQR 1.39	RARE 1.36	BPMC 1.36	RETA 1.21	HALO 1.17	WVE 1.02	ALNY 1.00
Quick Ratio	0.65	15/18	INCY 129.01	HALO 23.40	EXEL 21.86	UTHR 14.25	BMRN 0.66	ALNY -1.00	RETA -1.00	SGEN -1.00	RARE -1.00	MDGL -1.00	BPMC -1.00	WVE -1.00	APLS -1.00	KRYS -1.00	PRQR -1.00	ISEE -1.00	KRTX -1.00	DAWN -1.00
Long Term Debt to Equity	-771.20	18/18	HALO} 5.19	WVE} 4.94	RARE} 1.95	RETA} 1.87	APLS} 1.73	BPMC} 1.72	ISEE} 0.20	BMRN} 0.11	EXEL} 0.09	SGEN} 0.04	UTHR} 0.02	INCY} 0.01	KRTX} 0.01	MDGL} 0.00	KRYS} 0.00	PRQR} 0.00	DAWN} 0.00	ALNY} -771.20
Debt to Equity	-883.03	18/18	WVE 6.57	HALO 5.30	BPMC 2.31	RARE 2.14	RETA 1.90	APLS 1.80	PRQR 0.54	BMRN 0.21	ISEE 0.20	EXEL 0.09	UTHR 0.09	SGEN 0.04	INCY 0.01	KRYS 0.01	KRTX 0.01	MDGL 0.00	DAWN 0.00	ALNY -883.03
Burn Rate	7.05	4/18	DAWN 53.79	BMRN 22.62	PRQR 19.19	ALNY 7.05	APLS 6.29	ISEE 6.26	WVE 4.33	MDGL 3.25	RARE 2.71	INCY 2.20	SGEN 1.95	KRTX 1.61	BPMC 0.54	RETA -0.26	EXEL -0.91	HALO -7.37	UTHR -7.79	KRYS -22.71
Cash to Cap	0.03	12/18	PRQR 0.59	WVE 0.23	DAWN 0.20	MDGL 0.10	RARE 0.09	UTHR 0.09	INCY 0.08	APLS 0.08	ISEE 0.08	BMRN 0.07	KRYS 0.07	ALNY 0.03	EXEL 0.03	HALO 0.02	RETA 0.01	SGEN 0.01	BPMC 0.01	KRTX 0.01
CCR	-6.88	18/18	DAWN 15.03	PRQR 2.37	INCY 1.42	BPMC 1.01	KRTX 0.98	BMRN 0.90	WVE 0.83	ISEE 0.72	UTHR 0.67	RARE 0.62	HALO 0.57	SGEN 0.37	APLS 0.22	EXEL 0.00	MDGL 0.00	KRYS -0.34	RETA -0.36	ALNY -6.88
EV to EBITDA	578.57	1/18	ALNY} 578.57	KRYS} 213.08	BMRN} 105.23	HALO} 67.14	UTHR} 42.49	EXEL} 27.73	ISEE} -1.00	DAWN} -8.49	WVE} -16.98	INCY} -25.49	MDGL} -28.11	PRQR} -32.74	RARE} -53.56	RETA} -82.50	KRTX} -96.25	APLS} -153.54	BPMC} -160.91	SGEN} -191.83
EV to Revenue	15.70	8/18	KRTX 19006.33	MDGL 312.10	RETA 273.97	DAWN 110.92	KRYS 31.15	SGEN 18.62	BPMC 17.49	ALNY 15.70	RARE 11.96	HALO 10.58	APLS 7.44	PRQR 5.93	UTHR 5.50	WVE 5.04	EXEL 3.80	INCY 3.01	BMRN 0.02	ISEE -1.00

Alnylam Pharmaceuticals, Inc. Peer Comparison

Cookies